These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1173046)

  • 1. [Effect of 1-desamino-8-D-arginine-vasopressin in limited renal function].
    Scheitza E
    Arzneimittelforschung; 1975 Feb; 25(2):260-2. PubMed ID: 1173046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of two analogues of arginine-vasopressin (ornithine-vasopressin and desamino-D-arginine-vasopressin) on kidney function in sheep.
    Yesberg NE; Henderson M; Budtz-Olsen OE
    Q J Exp Physiol Cogn Med Sci; 1978 Apr; 63(2):179-88. PubMed ID: 247535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients.
    Bragadottir G; Redfors B; Nygren A; Sellgren J; Ricksten SE
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1052-9. PubMed ID: 19572935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
    Tuschy U; Meinhold J; Szeszat S
    Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolonged administration of vasopressin on plasma sodium and on renal excretion of electrolytes and water.
    Chan WY
    J Pharmacol Exp Ther; 1971 Jul; 178(1):141-51. PubMed ID: 5087392
    [No Abstract]   [Full Text] [Related]  

  • 7. The urinary excretion of selenium in sheep treated with a vasopressin analogue.
    Leng L; Boldizárová K; Faix S; Kovác G
    Vet Res; 2000; 31(5):499-505. PubMed ID: 11050745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostaglandin synthesis and the action of vasopressin during extracellular volume expansion in the dog.
    Kövér G; Szemerédi K; Tost H
    Acta Physiol Hung; 1983; 61(3):169-84. PubMed ID: 6650187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
    Kutyrina IM; Nikishova TA; Tareyeva IE
    Nephrol Dial Transplant; 1987; 2(4):219-23. PubMed ID: 3118260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the mechanism of vasopressin escape: effects of chronic vasopressin and overhydration on renal tissue osmolality and electrolytes in dogs.
    Chan WY
    J Pharmacol Exp Ther; 1973 Jan; 184(1):244-51. PubMed ID: 4686011
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E; Minetti EE; Cozzi MG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.
    Caltabiano S; Kinter LB
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Ringer solution induced extracellular volume expansion on kidney function.
    Kövér G; Tost H; Darvasi A
    Acta Physiol Hung; 1989; 74(2):141-60. PubMed ID: 2603731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
    Vávra I; Machová A; Krejcí I
    J Pharmacol Exp Ther; 1974 Jan; 188(1):241-7. PubMed ID: 4809272
    [No Abstract]   [Full Text] [Related]  

  • 16. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kidney circulation in chronic parenchyma diseases and in kidney insufficiency].
    Buchali K; Zimmermann HB
    Z Urol Nephrol; 1977 May; 70(5):305-9. PubMed ID: 899309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the highly selective kappa opioid, U-50, 488, on renal function in the anesthetized dog.
    Slizgi GR; Taylor CJ; Ludens JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):641-5. PubMed ID: 6088759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
    Brink HS; Derkx FH; Boomsma F; Schalekamp MA
    Clin Nephrol; 1994 Aug; 42(2):95-101. PubMed ID: 7955585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.